MTSS1 is a metastasis driver in a subset of human melanomas

Nature Communications

Volumn 5, Issue , 2014, Pages

  Mertz, Kirsten D ^a,i   Pathria, Gaurav ^a   Wagner, Christine ^a   Saarikangas, Juha ^b,j   Sboner, Andrea ^c   Romanov, Julia ^a   Gschaider, Melanie ^a   Lenz, Florian ^d   Neumann, Friederike ^d   Schreiner, Wolfgang ^d   Nemethova, Maria ^e   Glassmann, Alexander ^f,k   Lappalainen, Pekka ^b   Stingl, Georg ^a   Small, J Victor ^e   Fink, Dieter ^g   Chin, Lynda ^h   Wagner, Stephan N ^a,e  

^a Universitatsklinik fur Dermatologie   (Austria)

^b UNIVERSITY OF HELSINKI   (Finland)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^f UNIVERSITY OF BONN   (Germany)

^g UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^h UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

ⁱ Kantonsspital Liestal   (Switzerland)

^j ETH ZURICH   (Switzerland)

^k Life Science Inkubator   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; COFILIN; METASTASIS SUPPRESSOR 1 PROTEIN; PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

CANCER; DISEASE TREATMENT; ENZYME ACTIVITY; FUNCTIONAL ROLE; GENE EXPRESSION; GENOME; PROTEIN; PUBLIC HEALTH; SKIN DISORDER;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; GAIN OF FUNCTION MUTATION; GENE DOSAGE; GENE EXPRESSION; GENETIC SCREENING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SURVIVAL; SURVIVAL TIME; TIME LAPSE IMAGING; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MICE, NUDE; MICROFILAMENT PROTEINS; NEOPLASM METASTASIS; NEOPLASM PROTEINS;

EID: 84896540239     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4465     Document Type: Article

References (68)

1. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
2. Jabbour, E. & Kantarjian, H. Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management. Am. J. Hematol. 87, 1037-1045 (2012).
3. Beroukhim, R. et al. The landscape of somatic copy-number alteration across human cancers. Nature 463, 899-905 (2010).
4. Lin, W. M. et al. Modeling genomic diversity and tumor dependency in malignant melanoma. Cancer Res. 68, 664-673 (2008). (Pubitemid 351206741)
5. Berger, M. F. et al. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 485, 502-506 (2012).
6. Hodis, E. et al. A landscape of driver mutations in melanoma. Cell 150, 251-263 (2012).
7. Pleasance, E. D. et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463, 191-196 (2010).
8. Moran, C. Importance of molecular features of non-small cell lung cancer for choice of treatment. Am. J. Pathol. 178, 1940-1948 (2011).
9. Vidwans, S. J. et al. A melanoma molecular disease model. PLoS One 6, e18257 (2011).
10. Hodi, F. S. et al. Major response to imatinib mesylate in KIT-mutated melanoma. J. Clin. Oncol. 26, 2046-2051 (2008).
11. Garraway, L. A. et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436, 117-122 (2005). (Pubitemid 40966196)
12. Curtin, J. A. et al. Distinct sets of genetic alterations in melanoma. New Engl. J. Med. 353, 2135-2147 (2005). (Pubitemid 41653105)
13. Flaherty, K. T. et al. Inhibition of mutated, activated BRAF in metastatic melanoma. New Engl. J. Med. 363, 809-819 (2010).
14. Wagle, N. et al. Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. J. Clin. Oncol. 29, 3085-3096 (2011).
15. Shi, H. et al. Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance. Nat. Commun. 3, 724 (2012).
16. Solit, D. B. & Rosen, N. Resistance to BRAF inhibition in melanomas. New Engl. J. Med. 364, 772-774 (2011).
17. Akavia, U. D. et al. An integrated approach to uncover drivers of cancer. Cell 143, 1005-1017 (2010).
18. Valastyan, S. & Weinberg, R. A. Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275-292 (2011).
19. Xu, L. et al. Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases. Mol. Cancer Res. 6, 760-769 (2008).
20. Kabbarah, O. et al. Integrative genome comparison of primary and metastatic melanomas. PLoS One 5, e10770 (2010).
21. Kozlowski, J. M., Hart, I. R., Fidler, I. J. & Hanna, N. A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J. Natl. Cancer Inst. 72, 913-917 (1984). (Pubitemid 14131734)
22. Liu, B. A. et al. SRC Homology 2 Domain Binding Sites in Insulin, IGF-1 and FGF receptor mediated signaling networks reveal an extensive potential interactome. Cell Commun. Signal 10, 27 (2012).
23. Krishnan, V., Bane, S. M., Kawle, P. D., Naresh, K. N. & Kalraiya, R. D. Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium. Clin. Exp. Metastasis 22, 11-24 (2005). (Pubitemid 41185857)
24. Fons, R. D., Bogert, B. A. & Hegde, R. S. Substrate-specific function of the translocon-associated protein complex during translocation across the ER membrane. J. Cell Biol. 160, 529-539 (2003). (Pubitemid 36254391)
25. Machesky, L. M. & Johnston, S. A. MIM: a multifunctional scaffold protein. J. Mol. Med. 85, 569-576 (2007). (Pubitemid 46870900)
26. Saarikangas, J. et al. Molecular mechanisms of membrane deformation by I-BAR domain proteins. Curr. Biol. 19, 95-107 (2009).
27. Kim, M. et al. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 125, 1269-1281 (2006). (Pubitemid 43949521)
28. Scott, K. L. et al. Proinvasion metastasis drivers in early-stage melanoma are oncogenes. Cancer Cell 20, 92-103 (2011).
29. Van Raamsdonk, C. D. et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457, 599-602 (2009).
30. Hynes, R. O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69, 11-25 (1992).
31. Richardson, A., Malik, R. K., Hildebrand, J. D. & Parsons, J. T. Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by coexpression of Src or catalytically inactive FAK: a role for paxillin tyrosine phosphorylation. Mol. Cell Biol. 17, 6906-6914 (1997). (Pubitemid 27505920)
32. Minn, A. J. et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J. Clin. Invest. 115, 44-55 (2005). (Pubitemid 40385504)
33. Lim, E. et al. Monitoring tumor metastases and osteolytic lesions with bioluminescence and micro CT imaging. J. Vis. Exp. 50, e2775 (2011).
34. Mattila, P. K. et al. Missing-in-metastasis and IRSp53 deform PI(4,5)P2-rich membranes by an inverse BAR domain-like mechanism. J. Cell Biol. 176, 953-964 (2007). (Pubitemid 46506969)
35. Mattila, P. K., Salminen, M., Yamashiro, T. & Lappalainen, P. Mouse MIM, a tissue-specific regulator of cytoskeletal dynamics, interacts with ATP-actin monomers through its C-terminal WH2 domain. J. Biol. Chem. 278, 8452-8459 (2003). (Pubitemid 36800596)
36. Dawson, J. C., Timpson, P., Kalna, G. & Machesky, L. M. Mtss1 regulates epidermal growth factor signaling in head and neck squamous carcinoma cells. Oncogene 31, 1781-1793 (2012).
37. Bompard, G., Sharp, S. J., Freiss, G. & Machesky, L. M. Involvement of Rac in actin cytoskeleton rearrangements induced by MIM-B. J. Cell Sci. 118, 5393-5403 (2005). (Pubitemid 41819600)
38. Ridley, A. J. Life at the leading edge. Cell 145, 1012-1022 (2011).
39. Saarikangas, J. et al. Missing-in-metastasis MIM/MTSS1 promotes actin assembly at intercellular junctions and is required for integrity of kidney epithelia. J. Cell Sci. 124, 1245-1255 (2011).
40. Breitsprecher, D. et al. Molecular mechanism of Ena/VASP-mediated actinfilament elongation. EMBO J. 30, 456-467 (2011).
41. Kiuchi, T., Ohashi, K., Kurita, S. & Mizuno, K. Cofilin promotes stimulusinduced lamellipodium formation by generating an abundant supply of actin monomers. J. Cell Biol. 177, 465-476 (2007). (Pubitemid 46718275)
42. Lai, F. P. et al. Arp2/3 complex interactions and actin network turnover in lamellipodia. EMBO J. 27, 982-992 (2008). (Pubitemid 351508144)
43. Bernstein, B. W. & Bamburg, J. R. ADF/cofilin: a functional node in cell biology. Trends Cell Biol. 20, 187-195 (2010).
44. Wang, W., Eddy, R. & Condeelis, J. The cofilin pathway in breast cancer invasion and metastasis. Nat. Rev. Cancer 7, 429-440 (2007). (Pubitemid 46809168)
45. Yang, N. et al. Cofilin phosphorylation by LIM-kinase 1 and its role in Racmediated actin reorganization. Nature 393, 809-812 (1998). (Pubitemid 28299495)
46. Maekawa, M. et al. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 285, 895-898 (1999). (Pubitemid 29381991)
47. Ramaswamy, S., Ross, K. N., Lander, E. S. & Golub, T. R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49-54 (2003). (Pubitemid 36068681)
48. Gschaider, M. et al. An attempt at a molecular prediction of metastasis in patients with primary cutaneous melanoma. PLoS One 7, e49865 (2012).
49. Ferber, M. J. et al. Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene 22, 7233-7242 (2003). (Pubitemid 37378556)
50. Gotter, A. L. et al. A palindrome-driven complex rearrangement of 22q11.2 and 8q24.1 elucidated using novel technologies. Genome Res. 17, 470-481 (2007). (Pubitemid 46556451)
51. van Duin, M. et al. High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer. Genes Chromosomes Cancer 44, 438-449 (2005). (Pubitemid 41476795)
52. van Duin, M. et al. High-resolution array comparative genomic hybridization of chromosome 8q: evaluation of putative progression markers for gastroesophageal junction adenocarcinomas. Cytogenet. Genome Res. 118, 130-137 (2007). (Pubitemid 350125249)
53. Horlings, H. M. et al. Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients. Clin. Cancer Res. 16, 651-663 (2010).
54. Nixdorf, S. et al. Expression and regulation of MIM (Missing In Metastasis), a novel putative metastasis suppressor gene, and MIM-B, in bladder cancer cell lines. Cancer Lett. 215, 209-220 (2004). (Pubitemid 39370039)
55. Lee, Y. G., Macoska, J. A., Korenchuk, S. & Pienta, K. J. MIM, a potential metastasis suppressor gene in bladder cancer. Neoplasia 4, 291-294 (2002). (Pubitemid 34755838)
56. Loberg, R. D., Logothetis, C. J., Keller, E. T. & Pienta, K. J. Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype. J. Clin. Oncol. 23, 8232-8241 (2005). (Pubitemid 46211560)
57. Xie, F. et al. The impact of Metastasis Suppressor-1, MTSS1, on oesophageal squamous cell carcinoma and its clinical significance. J. Transl. Med. 9, 95 (2011).
58. Parr, C. & Jiang, W. G. Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer. Eur. J. Cancer 45, 1673-1683 (2009).
59. Ma, S., Guan, X. Y., Lee, T. K. & Chan, K. W. Clinicopathological significance of missing in metastasis B expression in hepatocellular carcinoma. Hum. Pathol. 38, 1201-1206 (2007). (Pubitemid 47058158)
60. Glassmann, A. et al. Developmental expression and differentiation-related neuron-specific splicing of metastasis suppressor 1 (Mtss1) in normal and transformed cerebellar cells. BMC Dev. Biol. 7, 111 (2007).
61. Quinones, G. A., Jin, J. & Oro, A. E. I-BAR protein antagonism of endocytosis mediates directional sensing during guided cell migration. J. Cell Biol. 189, 353-367 (2010).
62. Ridley, A. J. & Hall, A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70, 389-399 (1992).
63. Lin, J. et al. Differential regulation of cortactin and N-WASP-mediated actin polymerization by missing in metastasis (MIM) protein. Oncogene 24, 2059-2066 (2005). (Pubitemid 40516199)
64. Liu, W. et al. MIM regulates vertebrate neural tube closure. Development 138, 2035-2047 (2011).
65. Quinones, G. A. & Oro, A. E. BAR domain competition during directional cellular migration. Cell Cycle 9, 2522-2528 (2010).
66. Cox, D. R. Regression models and life-tables. J. Roy. Stat. Soc. B 34, 187-220 (1972).
67. Auinger, S. & Small, J. V. Correlated light and electron microscopy of the actin cytoskeleton. Methods Cell Biol. 88, 257-272 (2007).
68. Hecker, D., Kappler, J., Glassmann, A., Schilling, K. & Alt, W. Image analysis of time-lapse movies - a precision control guided approach to correct motion artefacts. J. Neurosci. Methods 172, 67-73 (2008).